trending Market Intelligence /marketintelligence/en/news-insights/trending/l3Unk043-6Vzmh8Enr5Lrg2 content esgSubNav
In This List

Regenxbio appoints chief scientific officer

Case Study

Identifying PPE Suppliers During the Pandemic

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective


Regenxbio appoints chief scientific officer

Regenxbio Inc. appointed Olivier Danos to the newly created position of chief scientific officer.

Danos will be reporting to Kenneth Mills, the company's president and CEO. Danos was most recently the senior vice president of cell and gene therapy at Biogen Inc.